Acute cardiac care & resuscitation

Sex differences in mechanical circulatory support efficacy in infarct-related cardiogenic shock. An individual patient data meta-analysis

Eur Heart J Acute Cardiovasc CarePublished individual patient data meta-analysis

Authors' conclusion

Women with AMI-CS were underrepresented and had higher mortality than men. No sex-specific treatment effect was observed overall, whereas subgroup findings suggested possible heterogeneity in DanGer-Shock-like patients. These findings, limited by small number of female patients and wide confidence intervals, support the need for adequately powered trials with sufficient female representation.

Study context

Population
Patients with infarct-related cardiogenic shock (AMI-CS) in randomized trials comparing early routine mechanical circulatory support (MCS) with standard careNine trials, 213 (20%) female and 845 male patients · 213 (female) · 845 (male)
Comparison
Early routine MCS with standard care in AMI-CS, by sex
Outcome
All-cause mortality
Follow-up
6 months
Methodological detailsrandomized trials, study-stratified Cox models
  • Randomized trials
  • Study-stratified Cox models

Pooled result

As reported in the abstract

All-cause mortality
Early routine MCS vs Standard careHazard ratio (95% CI)P value
Women
0.99(0.70–1.42)
Men
0.84(0.70–1.02)
P = 0.41for interaction

Further pooled results

Mortality among DanGer Shock-like patients (subgroup) · Early routine MCS vs Standard care

OutcomeHR (95% CI)P value
Men0.66 (0.51–0.86)
Women1.18 (0.72–1.91)P for interaction = 0.02

Age, women vs men

6-month mortality, women vs men

  • Age, women vs men: P < 0.001
  • 6-month mortality, women vs men: P = 0.03

Original publication

Sex differences in mechanical circulatory support efficacy in infarct-related cardiogenic shock. An individual patient data meta-analysis. Eur Heart J Acute Cardiovasc Care. Published 16 November 2026. doi:10.1093/ehjacc/zuag141

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.